Martha Stewart Legal Case: Complete Criminal Case Brief

The Martha Stewart criminal case remains one of the most widely discussed white-collar crime prosecutions in American legal history. The case — arising from the ImClone Systems stock scandal — resulted in the conviction and imprisonment of one of America's most successful and recognizable business personalities. Yet the case carries significant legal complexity: Stewart was not ultimately convicted of insider trading itself, but rather of the cover-up that followed. This case brief provides a comprehensive legal analysis of why Martha Stewart went to jail, what charges she faced, the trial proceedings, her conviction and sentence, and the broader implications for securities law and corporate accountability.

Case Overview at a Glance

Case Name and Citation

United States v. Martha Stewart and Peter Bacanovic, Case No. S1 03 Cr. 717 (S.D.N.Y. 2004); affirmed, 433 F.3d 273 (2d Cir. 2006)

Court

United States District Court for the Southern District of New York; affirmed by the United States Court of Appeals for the Second Circuit

Presiding Judge — Trial

Judge Miriam Goldman Cedarbaum, U.S. District Court, Southern District of New York

Verdict

Guilty — March 5, 2004 (jury verdict after three days of deliberation)

Sentence

Five months in federal prison; five months of home confinement; two years of probation — imposed July 16, 2004

Related Civil Action

SEC v. Martha Stewart and Peter Bacanovic — settled August 2006

Background: Who Is Martha Stewart?

Martha Stewart (born 1941) is an American businesswoman, television personality, author, and media executive. She built a media empire centered on home management, cooking, decorating, and entertaining, founding Martha Stewart Living Omnimedia (MSLO), which was listed on the New York Stock Exchange under the ticker symbol MSO. By the early 2000s, Stewart was one of the most powerful and recognizable figures in American business — named to Forbes 400, Fortune's 50 Most Powerful Women, and Time's 25 Most Influential People.

In December 2001, Stewart owned approximately 3,928 shares of stock in ImClone Systems, Inc., a biopharmaceutical company based in New York. ImClone's founder and CEO was Samuel D. Waksal — a personal friend and social acquaintance of Stewart. Both Stewart and Waksal shared the same financial broker at Merrill Lynch: Peter Bacanovic.

The ImClone Stock Scandal: What Happened

ImClone Systems and the Erbitux FDA Rejection

ImClone Systems had been developing Erbitux, an experimental monoclonal antibody drug intended for use in treating colorectal cancer. In late 2001, ImClone was awaiting a critical FDA decision on whether to accept its Biologics License Application (BLA) for Erbitux. The company's stock price and market prospects were heavily dependent on FDA approval.

On December 26, 2001, ImClone received notice from the FDA that it had refused to file — that is, declined to even review — the BLA for Erbitux, effectively rejecting the application due to incomplete clinical data. This was devastating news for ImClone's stock. The announcement was made public after the close of trading on December 28, 2001. ImClone's stock price dropped approximately 16% in response.

The Insider Trading at ImClone

Before the FDA rejection became public, Samuel Waksal received advance knowledge of the agency's decision. On December 27, 2001 — the day before the public announcement — Waksal attempted to sell the entirety of his personal ImClone holdings through Merrill Lynch. Merrill Lynch blocked the transfer, but Waksal's daughter Aliza did successfully sell her ImClone shares. Additionally, ImClone's in-house counsel and multiple senior executives sold substantial blocks of company stock in the days before the announcement.

The Critical Phone Call — December 27, 2001

Peter Bacanovic, who was on vacation at the time, learned through his assistant Douglas Faneuil that Waksal was attempting to liquidate his ImClone holdings. Bacanovic immediately called Stewart's office and left a message at 10:04 a.m. that was recorded by Stewart's personal assistant Ann Armstrong as: 'Peter Bacanovic thinks ImClone is going to start trading downward.'

Later that same day, Stewart called Bacanovic's office and spoke to Faneuil, who — acting on Bacanovic's instructions — informed her that the Waksal family was dumping their ImClone stock. Upon receiving this tip, Stewart directed Faneuil to sell all of her 3,928 ImClone shares. The sale was executed that afternoon at an average price of $58.43 per share, generating proceeds of approximately $228,000. By selling before the public announcement, Stewart avoided a loss of approximately $51,222.

The Government Investigation

By early 2002, the Martha Stewart ImClone case had attracted scrutiny from multiple government agencies simultaneously: the House Energy and Commerce Committee, the Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the U.S. Attorney's Office for the Southern District of New York had all commenced investigations into trading activity in ImClone stock in the days preceding the FDA announcement.

Stewart's Fabricated Defense

When investigators first approached Stewart and Bacanovic, both parties advanced a coordinated false explanation for the stock sale. Stewart and Bacanovic claimed that the sale was the result of a pre-existing standing agreement between them: they alleged that Stewart had previously instructed Bacanovic to sell her ImClone shares automatically if the stock ever fell below $60 per share — a so-called 'stop-loss order.'

In support of this fabricated narrative, Bacanovic's assistant later discovered that a notation had been added to a broker's worksheet documenting the $60 agreement — using ink that forensic analysis subsequently showed was different from the other ink on the document, suggesting the notation was added after the fact. Additionally, before her February 4, 2002 interview with investigators, Stewart accessed her assistant's computer and altered the logged record of Bacanovic's December 27 phone message, initially changing it to simply read 'Peter Bacanovic re: ImClone' — before her assistant persuaded her to restore the original language.

The Whistleblower — Douglas Faneuil

The investigation broke open when Douglas Faneuil, Bacanovic's assistant, disclosed to investigators the true nature of the December 27 phone call. Faneuil admitted that he had not truthfully revealed everything he knew about the actions of his immediate supervisor and the true reason for the sales. Faneuil pleaded guilty to a misdemeanor charge in October 2002 and cooperated with prosecutors, providing crucial testimony against both Stewart and Bacanovic.

Criminal Charges Against Martha Stewart

Charges in the Indictment

Martha Stewart and Peter Bacanovic were charged in a superseding indictment, Case No. S1 03 Cr. 717, with multiple criminal counts arising from their conduct in connection with the investigation — not from the stock trade itself.

• Count One: Conspiracy to obstruct justice, make false statements, and commit perjury (18 U.S.C. § 371) — charged against both Stewart and Bacanovic jointly
• Count Two: Making false statements to federal investigators (18 U.S.C. § 1001) — Bacanovic's false statement about the $60 stop-loss agreement
• Count Three: Making false statements to federal investigators (18 U.S.C. § 1001) — Stewart's multiple false statements during her February 4, 2002 interview
• Count Four: Obstruction of justice (18 U.S.C. § 1505) — relating to Stewart's alteration of the phone message log
• Securities fraud charge (Count Nine): Dropped by the trial judge before submission to the jury — this was the charge most directly related to Stewart's public statements about her innocence potentially affecting her own company's stock price

What Was Martha Stewart Convicted Of?

Stewart was NOT convicted of insider trading. This is a common misconception. She was convicted of three counts: (1) conspiracy to obstruct justice and make false statements; (2) making two specific false statements to federal investigators in violation of 18 U.S.C. § 1001; and (3) obstruction of an SEC proceeding in violation of 18 U.S.C. § 1505. Her convictions arose entirely from the cover-up — the lies she told investigators — rather than from the underlying stock sale itself.

The Trial

Prosecution Strategy

The government's case was built around three key categories of evidence: (1) the testimony of Douglas Faneuil, who described in detail the December 27 tip and Stewart's response; (2) phone records and the broker's worksheet documenting the timeline of events; and (3) evidence of the coordinated false narrative that Stewart and Bacanovic advanced to investigators.

Stewart's Defense

Stewart pleaded not guilty throughout the proceedings. Her defense centered on the legitimacy of the $60 stop-loss agreement — insisting that the sale was routine and pre-planned rather than based on an insider tip. She maintained her innocence publicly, taking out a full-page advertisement in USA Today on the day of her indictment and launching a website with an open letter to supporters. Her defense team also challenged the credibility of Douglas Faneuil as a cooperating witness with an incentive to please prosecutors.

Verdict — March 5, 2004

After deliberating for three days, a jury of four men and eight women returned guilty verdicts against Martha Stewart on all four counts with which she was charged. The jury acquitted her of one false statement specification. Bacanovic was simultaneously convicted on multiple counts as well.

Martha Stewart's Sentence and Jail Time

Sentencing — July 16, 2004

Judge Cedarbaum sentenced Martha Stewart on July 16, 2004. The sentence consisted of five months in federal prison, five months of home confinement following her prison term, and two years of probation. Stewart was ordered to surrender to federal custody and was assigned to serve her sentence at the Federal Correctional Institution at Alderson, West Virginia (FCI Alderson) — a minimum security facility sometimes called 'Camp Cupcake' in tabloid media.

How Long Was Martha Stewart in Prison?

Martha Stewart served five months in federal prison, from October 8, 2004, to March 4, 2005 — the full term of her custodial sentence. Upon release from FCI Alderson, she served a further five months of home confinement at her Bedford, New York estate, wearing an electronic monitoring ankle bracelet.

The Civil Case: SEC Enforcement Action

Parallel to the criminal proceedings, the Securities and Exchange Commission filed a civil complaint against Stewart and Bacanovic in June 2003, charging them with violations of Section 17(a) of the Securities Act of 1933, Section 10(b) of the Securities Exchange Act of 1934, and Rule 10b-5 — the core antifraud provisions of federal securities law.

In August 2006, Stewart and Bacanovic agreed to settle the SEC civil enforcement action. Under the settlement, Stewart agreed to pay disgorgement of $45,673 (representing the losses she avoided), prejudgment interest of $12,389, and a civil penalty of $137,019 — totaling approximately $195,000. She also agreed to a five-year bar from serving as a director of any public company and a five-year limitation on her service as an officer or senior financial employee of any public company.

Legal Analysis: Key Legal Issues

The Insider Trading Question

Technically, Martha Stewart was never convicted of insider trading. Legal scholars have noted significant complexity in the insider trading theory as it applied to Stewart. The applicable legal framework — rooted in the misappropriation theory articulated by the Supreme Court in United States v. O'Hagan (1997) — requires proof that the tipper (Bacanovic) breached a duty of confidentiality and that the tippee (Stewart) knew of that breach. The SEC's insider trading theory as applied to Stewart faced difficult questions of proof at multiple levels.

18 U.S.C. § 1001 — False Statements to Federal Officials

The convictions that ultimately sent Stewart to prison turned on 18 U.S.C. § 1001, which makes it a federal felony to knowingly and willfully make any materially false, fictitious, or fraudulent statement or representation to a federal official in connection with a matter within the jurisdiction of the executive or judicial branch. The critical lesson of the Stewart case — which has been widely cited in subsequent corporate compliance training — is that the cover-up is often legally riskier than the underlying conduct.

White Collar Crime and Equal Justice Debates

The Martha Stewart case generated significant debate about the fair and equal application of white collar criminal laws. Critics argued that Stewart — whose avoided loss of $51,222 was modest by the standards of the contemporaneous Enron and WorldCom scandals — was prosecuted with disproportionate vigor given the relatively limited financial harm involved. Others, including prosecutors, argued that the prosecution was necessary to establish that the law applied equally to the wealthy and powerful. The case became a touchstone in national discussions about corporate accountability, gender bias in prosecution, and the boundaries of white collar criminal enforcement.

Aftermath and Career Recovery

Despite her conviction, Martha Stewart's post-prison career demonstrated remarkable resilience. She returned to television programming, launched new business ventures, and rebuilt her brand. Martha Stewart Living Omnimedia, which had suffered significant stock price declines during the scandal and legal proceedings, eventually merged with Sequential Brands Group. Stewart has continued to be a prominent public figure in media, business, and entertainment.

The SEC civil settlement, finalized in 2006, resolved the last formal legal proceeding against her. In October 2005, Stewart was found inadmissible to Canada due to her felony conviction under Canadian immigration law — a reminder that criminal convictions carry collateral consequences beyond the sentence itself.

Key Takeaways for Securities Law and Compliance

• The most serious legal risk in any securities investigation is not necessarily the underlying trade but the false statements and obstruction that may follow during the investigation.
• 18 U.S.C. § 1001 — criminalizing false statements to federal officials — applies broadly and carries significant exposure for anyone interviewed in connection with a federal securities investigation.
• Trading on a tip from a broker who learned that a major shareholder was urgently liquidating shares implicates the misappropriation theory of insider trading liability under Rule 10b-5.
• The SEC's civil enforcement action and criminal prosecution operate independently — a defendant can settle one without resolving the other.
• Even relatively modest financial gains from questionable stock trades can generate criminal liability if the subsequent cover-up involves false statements, obstruction, or conspiracy.

References & Further Reading

• United States v. Stewart, 433 F.3d 273 (2d Cir. 2006)
• Superseding Indictment, S1 03 Cr. 717 (S.D.N.Y. 2003)
• 18 U.S.C. § 1001 — False Statements
• 18 U.S.C. § 1505 — Obstruction of Proceedings
• Securities Exchange Act of 1934, Section 10(b); Rule 10b-5
• United States v. O'Hagan, 521 U.S. 642 (1997) — Misappropriation Theory
• SEC Litigation Release No. 19794 (Aug. 7, 2006) — Civil Settlement